PLUSCompliance•globenewswire•
Plus Therapeutics Reports Stockholders’ Equity in Excess of $2.5 million in Compliance with Nasdaq Equity Requirements
Sentiment:Neutral (40)
Summary
Plus Therapeutics Reports Stockholders’ Equity in Excess of $2.5 million in Compliance with Nasdaq Equity Requirements
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 15, 2025 by globenewswire